Pharming Group N.V. (PHAR) Free cash flow 2019–2025
Pharming Group N.V. (PHAR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$54.0MFY2025 · since FY2019: $71.5M → $54.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.0M | +2187.4% |
| FY2024 | -$2.6M | +86.2% |
| FY2023 | -$18.7M | -188.9% |
| FY2022 | $21.1M | -22.2% |
| FY2021 | $27.1M | -65.7% |
| FY2020 | $79.0M | +10.4% |
| FY2019 | $71.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR RevenuePHAR Net incomePHAR Net marginPHAR Gross profitPHAR Gross marginPHAR Operating incomePHAR Operating marginPHAR Operating cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →